Advanced discussions to merge Smith & Nephew with Johnson & Johnson’s orthopaedics division broke down over leadership of the proposed combined business, the Financial Times reported on 23 October, according to Reuters. The parties were said to have agreed on the principal financial terms and transaction structure, but Smith & Nephew sought to retain CEO Deepak Nath while J&J favoured Namal Nawana. Reuters reported the J&J hip-and-knee unit could have been valued at as much as $22 billion in the contemplated transaction. Smith & Nephew declined comment, and J&J had not provided ConfirmationEvidence that supports an idea after price reaches an area of interest, such as a close, structure break, or strong rejection. It reduces guessing but can mean a later entry.Read More in the report. No merger agreement had been signed or officially terminated.
Merger discussions between Smith & Nephew and Johnson & Johnson's orthopaedics business have reportedly collapsed following disagreements over leadership arrangements, according to the Financial Times. The BreakdownA breakdown occurs when price moves below a meaningful support level, range floor, trend boundary, or pattern boundary and the move is accepted rather than immediately rejected....Read More highlights challenges in negotiating major healthcare industry transactions. Investors are monitoring potential implications for both companies' strategic plans, MarketA place—physical or digital—where buyers and sellers meet and agree on a price. Lix’s simple rule: no buyers and sellers, no market.Read More competition and future ConsolidationA tight or contained period where price pauses and balances after moving. It can resolve in either direction.Read More opportunities in the medical devices sector.
